Krypton Gefitinib 250mg Tablet
Marketer
Krypton Global Health
Salt Composition
Gefitinib (250mg)
Overview Krypton Gefitinib 250mg Tablet
Gefitinib 250mg tablets (Krypton brand) treat advanced non-small cell lung cancer. This medication is for patients with metastatic disease, abnormal epidermal growth factor receptor (EGFR) genes, and no prior cancer treatment. Dosage should follow your physician's instructions; continue taking it as directed. Treatment length depends on individual response. Your doctor may recommend regular liver function tests. Common side effects are diarrhea, dry skin, appetite loss, and nausea. Increased fluid intake may lessen side effects. Report any bothersome or worsening side effects. Immediately notify your physician if you experience mouth sores, vision changes, or breathing problems. Women should use reliable contraception throughout treatment and for one month afterward to prevent pregnancy. Disclose all other medications you are currently using to your doctor.
Uses of Krypton Gefitinib 250mg Tablet
Lung cancer (non-small cell type)
Major Benefits of Krypton Gefitinib 250mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 250mg Krypton Gefitinib tablet whole; avoid chewing, crushing, or breaking it. While food is not mandatory, consistent timing is recommended for optimal results.
Common Side effects of Krypton Gefitinib 250mg Tablet:
- Diarrhea
- Dry skin
- Loss of appetite
- Nausea
- Rash
- Vomiting
- Weakness
- Weight loss
- Eating disorder
- Allergic reaction
How to use Krypton Gefitinib 250mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 250mg Krypton Gefitinib tablet whole; avoid chewing, crushing, or breaking it. While it can be taken with or without food, consistency in timing is recommended.
How Krypton Gefitinib 250mg Tablet works:
Gefitinib 250mg tablets (Krypton brand) are an anticancer drug. Their mechanism involves inhibiting the activity of a mutated protein responsible for cancerous cell proliferation, thus hindering or retarding tumor growth.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Krypton Gefitinib 250mg tablets is unsafe.
PregnancyCONSULT YOUR DOCTOR
Gefitinib 250mg tablets (Krypton brand) pose a confirmed risk to a fetus and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Gefitinib 250mg tablets (Krypton) likely pose a risk to breastfeeding infants. Available human data indicates potential transfer to breast milk, potentially harming the nursing child.
DrivingUNSAFE
Gefitinib 250mg tablets (Krypton) can induce adverse reactions that may impair driving capabilities.
KidneyCAUTION
Gefitinib 250mg tablets (Krypton brand) require careful administration for individuals with significant kidney impairment. Dosage modification may be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Gefitinib 250mg tablets (Krypton) appear to be well-tolerated by individuals with hepatic impairment. Current evidence indicates dose modification may not be necessary; however, physician consultation is recommended.
What if you forget to take Krypton Gefitinib 250mg Tablet :
Omit any missed Krypton Gefitinib 250mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Krypton Gefitinib 250mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Quinazoline amines |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
3,018 People bought this recently